Compare APP & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APP | MCK |
|---|---|---|
| Founded | 2012 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.6B | 106.8B |
| IPO Year | 2021 | 1995 |
| Metric | APP | MCK |
|---|---|---|
| Price | $465.45 | $868.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 13 |
| Target Price | $694.44 | ★ $951.38 |
| AVG Volume (30 Days) | ★ 3.9M | 651.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ 115.23 | 14.87 |
| EPS | 9.75 | ★ 24.73 |
| Revenue | $5,480,717,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $47.43 | $14.97 |
| Revenue Next Year | $28.94 | $8.20 |
| P/E Ratio | $47.64 | ★ $34.86 |
| Revenue Growth | ★ 16.38 | 3.11 |
| 52 Week Low | $222.02 | $637.00 |
| 52 Week High | $745.61 | $999.00 |
| Indicator | APP | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 59.21 | 43.02 |
| Support Level | $357.19 | $796.22 |
| Resistance Level | $473.35 | $891.42 |
| Average True Range (ATR) | 26.52 | 17.47 |
| MACD | 9.50 | 1.18 |
| Stochastic Oscillator | 81.99 | 55.40 |
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.